Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FF
- Chemical substanceL01FF04Avelumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 3 registrations
- Bavencio 20 MG/ML Concentrado Para Solucion Para Perfusion200 mg mg · concentrado para solución para perfusión · Merck Europe B.V.
- Bavencio 20 MG/ML Concentrado Para Solucion Para Perfusion20 mg/ml · concentrado para solución para perfusión · Merck Europe B.V.
- Bavencio 20 MG/ML Concentrado Para Solucion Para Perfusion200 mg · concentrado para solución para perfusión · Merck Europe B.V.
Serbia
ALIMS · 2 registrations
United States
FDA · 2 registrations
At a glance
- ATC code
- L01FF04
- Registers
- 10
- Historical lists
- 2
- Registrations
- 17
- With their own page
- 14
- Companies
- 9
All medicines with Avelumab
Human medicines from every register that match Avelumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
17 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Bavencio | United States | 20MG/ML | injectable | Marketed | Emd Serono INC |
| Bavencio | United States | 20MG/ML | injectable | Marketed | Emd Serono INC |
| Bavencio | European Union | Authorised | Merck Europe B.V. | ||
| Bavencio 20 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 200 mg mg | concentrado para solución para perfusión | Marketed | Merck Europe B.V. |
| Bavencio 20 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 200 mg | concentrado para solución para perfusión | Marketed | Merck Europe B.V. |
| Bavencio 20 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 20 mg/ml | concentrado para solución para perfusión | Marketed | Merck Europe B.V. |
| Bavencio 20 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Merck Europe B.V. | |
| Bavencio | Canada | 20 MG / ML | Solution | Marketed | Emd Serono, A Division of Emd INC., Canada |
| Bavencio | Brazil | Authorised | Merck S/A | ||
| Bavencio® | Serbia | 20mg/mL | koncentrat za rastvor za infuziju | Authorised | Merck D.O.O. Beograd |
| Bavencio® | Serbia | 20mg/mL | koncentrat za rastvor za infuziju | Authorised | Merck D.O.O. Beograd |
| Bavencio 20mg/mL Concentrate for Solution for Infusion | Taiwan | 注射液劑 | Authorised | 台灣默克股份有限公司 | |
| Bavencio Concentrate for Solution for Infusion 200MG/10ML | Singapore | 200mg/10ml | injection, solution, concentrate | Authorised | Merck Pte. LTD. |
| Bavencio | Croatia | Marketed | |||
| Bavencio | Saudi Arabia | Authorised | Merck Serono | ||
| BAVENCIO 20 mg/ml | Romania | 20mg/ml | conc. pt. sol. perf. | Status unknown | Merck Europe B.V. |
| BAVENCIO 20mg/ml | Romania | 20mg/ml | conc. pt. sol. perf. | Status unknown | Merck Serono Europe Limited |